MedDataX Logo

The Link Between the Clinical Resting Heart Rate and Sympathetic Overactivation

NCT ID: NCT02315313

Last Updated: 2014-12-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It is a retrospective study with no products limitation to investigate the link between clinical resting HR and SOA. Use HR≤60bpm as control group, compare other three groups with the control group and find out the correlation between HR and SOA indexes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group1

RHR≤60bpm

No interventions assigned to this group

group2

RHR 61-70bpm

No interventions assigned to this group

group3

RHR 71-80bpm

No interventions assigned to this group

group4

RHR \>80bpm

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Provision of subject informed written or oral consent
2. Female and male aged≥ 20 to ≤ 80 years;
3. Records on mean clinical heart rate and SOA indexes were available.

Exclusion Criteria

1. Participation in another clinical study with an investigational product during the last 6 months;
2. Drug intervention on heart rate 1 month prior to the inclusion;
3. Patients with missing data in the database from the Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai.
Minimum Eligible Age

20 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ruijin Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Wang Jiguang

Director, The Shanghai Institute of Hypertension

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jiguang Wang, PHD

Role: CONTACT

Phone: 13764189476

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ESR-14-10153

Identifier Type: -

Identifier Source: org_study_id